Skip to main content
OpenTrials

Clinical trial condition

Drug/Agent Toxicity by Tissue/Organ

Explore clinical trials studying Drug/Agent Toxicity by Tissue/Organ. Study availability and eligibility vary by location and protocol.

30 public trials 0 recruiting studies
Refine in advanced search Browse all conditions

Drug/Agent Toxicity by Tissue/Organ trial results

Completed

Silymarin (Milk Thistle Extract) in Treating Patients With Acute Lymphoblastic Leukemia Who Are Receiving Chemotherapy

NCT00055718

Conditions
Chemically-Induced Disorders, Drug-Related Side Effects and Adverse Reactions, Drug/Agent Toxicity by Tissue/Organ, +11 more
Locations
  • Miami Children's Hospital Miami, Florida, United States
  • Winthrop University Hospital Mineola, New York, United States
  • Mount Sinai School of Medicine New York, United States
  • Herbert Irving Comprehensive Cancer Center at Columbia University New York, United States
View Trial Details
Completed

Bleomycin, Etoposide, and Cisplatin in Treating Patients With Metastatic Germ Cell Cancer of the Testicles

NCT00324298

Conditions
Chemically-Induced Disorders, Drug-Related Side Effects and Adverse Reactions, Drug/Agent Toxicity by Tissue/Organ, +14 more
Locations
  • Basildon University Hospital Basildon, England, United Kingdom
  • Addenbrooke's Hospital Cambridge, England, United Kingdom
  • Essex County Hospital Colchester, England, United Kingdom
  • Ipswich Hospital Ipswich, England, United Kingdom
View Trial Details
Completed

Combination Chemotherapy Plus Amifostine in Treating Children With Malignant Germ Cell Tumors

NCT00003811

Conditions
Adnexal Diseases, Chemically-Induced Disorders, Childhood Germ Cell Tumor, +27 more
Locations
  • University of Alabama at Birmingham Comprehensive Cancer Center Birmingham, Alabama, United States
  • MBCCOP - Gulf Coast Mobile, Alabama, United States
  • Arizona Cancer Center Tucson, Arizona, United States
  • University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
View all 110 locations
View Trial Details
Completed

Dexamethasone Followed by Denileukin Diftitox in Treating Patients With Persistent or Recurrent T-Cell Lymphoma

NCT00006345

Conditions
Chemically-Induced Disorders, Drug-Related Side Effects and Adverse Reactions, Drug/Agent Toxicity by Tissue/Organ, +13 more
Locations
  • Veterans Affairs Medical Center - Miami Miami, Florida, United States
  • Rush Cancer Institute Chicago, Illinois, United States
  • Tulane University School of Medicine New Orleans, Louisiana, United States
  • Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
View Trial Details
Completed

Amifostine, Chemotherapy, and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer

NCT00004176

Conditions
Chemically-Induced Disorders, Drug-Related Side Effects and Adverse Reactions, Drug/Agent Toxicity by Tissue/Organ, +11 more
Locations
  • Rocky Mountain Cancer Center Denver, Colorado, United States
  • Washington University Barnard Cancer Center St Louis, Missouri, United States
  • Lineberger Comprehensive Cancer Center, UNC Chapel Hill, North Carolina, United States
  • University of Pittsburgh Cancer Institute Pittsburgh, Pennsylvania, United States
View Trial Details

Related conditions